Ameriprise’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-18,199
| Closed | -$2.33M | – | 4069 |
|
|
2025
Q2 | $2.33M | Sell |
18,199
-343,309
| -95% | -$35.7M | ﹤0.01% | 2862 |
|
|
2025
Q1 | $32M | Buy |
361,508
+23,393
| +7% | +$2.28M | 0.01% | 1049 |
|
|
2024
Q4 | $29.5M | Buy |
338,115
+13,501
| +4% | +$1.24M | 0.01% | 1116 |
|
|
2024
Q3 | $30M | Buy |
324,614
+164,802
| +103% | +$16.4M | 0.01% | 1102 |
|
|
2024
Q2 | $17.2M | Buy |
159,812
+91,306
| +133% | +$9.14M | ﹤0.01% | 1373 |
|
|
2024
Q1 | $6.5M | Buy |
68,506
+7,590
| +12% | +$651K | ﹤0.01% | 2165 |
|
|
2023
Q4 | $5.62M | Buy |
60,916
+8,726
| +17% | +$565K | ﹤0.01% | 2258 |
|
|
2023
Q3 | $2.62M | Buy |
52,190
+4,045
| +8% | +$216K | ﹤0.01% | 2689 |
|
|
2023
Q2 | $3.04M | Sell |
48,145
-8,846
| -16% | -$481K | ﹤0.01% | 2665 |
|
|
2023
Q1 | $2.56M | Sell |
56,991
-6,598
| -10% | -$297K | ﹤0.01% | 2719 |
|
|
2022
Q4 | $2.79M | Sell |
63,589
-1,383
| -2% | -$66.3K | ﹤0.01% | 2656 |
|
|
2022
Q3 | $4.28M | Sell |
64,972
-8,030
| -11% | -$516K | ﹤0.01% | 2335 |
|
|
2022
Q2 | $3.69M | Buy |
73,002
+2,267
| +3% | +$133K | ﹤0.01% | 2494 |
|
|
2022
Q1 | $4.52M | Buy |
70,735
+21,029
| +42% | +$1.51M | ﹤0.01% | 2485 |
|
|
2021
Q4 | $5.32M | Buy |
49,706
+2,805
| +6% | +$293K | ﹤0.01% | 2413 |
|
|
2021
Q3 | $4.82M | Buy |
46,901
+2,679
| +6% | +$249K | ﹤0.01% | 2411 |
|
|
2021
Q2 | $3.89M | Buy |
44,222
+2,628
| +6% | +$241K | ﹤0.01% | 2617 |
|
|
2021
Q1 | $4.04M | Sell |
41,594
-6,170
| -13% | -$616K | ﹤0.01% | 2515 |
|
|
2020
Q4 | $5.36M | Sell |
47,764
-3,804
| -7% | -$401K | ﹤0.01% | 2224 |
|
|
2020
Q3 | $4.78M | Sell |
51,568
-9,574
| -16% | -$737K | ﹤0.01% | 2116 |
|
|
2020
Q2 | $4.77M | Sell |
61,142
-12,806
| -17% | -$866K | ﹤0.01% | 2100 |
|
|
2020
Q1 | $4.33M | Buy |
73,948
+49,405
| +201% | +$3.18M | ﹤0.01% | 2001 |
|
|
2019
Q4 | $1.97M | Sell |
24,543
-8,842
| -26% | -$662K | ﹤0.01% | 2738 |
|
|
2019
Q3 | $2.45M | Sell |
33,385
-31,992
| -49% | -$2.77M | ﹤0.01% | 2604 |
|
|
2019
Q2 | $6.17M | Buy |
65,377
+1,083
| +2% | +$89.4K | ﹤0.01% | 2091 |
|
|
2019
Q1 | $5.15M | Buy |
64,294
+60,079
| +1,425% | +$4.44M | ﹤0.01% | 2205 |
|
|
2018
Q4 | $227K | Buy |
+4,215
| New | +$256K | ﹤0.01% | 3411 |
|
|
2018
Q3 | – | Sell |
-29,454
| Closed | -$1.87M | – | 3727 |
|
|
2018
Q2 | $1.87M | Sell |
29,454
-33,264
| -53% | -$2.65M | ﹤0.01% | 2760 |
|
|
2018
Q1 | $5.75M | Sell |
62,718
-7,039
| -10% | -$607K | ﹤0.01% | 2074 |
|
|
2017
Q4 | $5.26M | Buy |
69,757
+15,499
| +29% | +$1.09M | ﹤0.01% | 2092 |
|
|
2017
Q3 | $3.78M | Buy |
+54,258
| New | +$2.9M | ﹤0.01% | 2280 |
|
|
2016
Q2 | – | Sell |
-47,014
| Closed | -$849K | – | 3781 |
|
|
2016
Q1 | $849K | Sell |
47,014
-64,738
| -58% | -$1.12M | ﹤0.01% | 2938 |
|
|
2015
Q4 | $2.94M | Buy |
111,752
+23,145
| +26% | +$521K | ﹤0.01% | 2395 |
|
|
2015
Q3 | $1.88M | Sell |
88,607
-107,489
| -55% | -$2.97M | ﹤0.01% | 2650 |
|
|
2015
Q2 | $5.19M | Buy |
+196,096
| New | +$5.6M | ﹤0.01% | 2128 |
|
Other funds holding BPMC
IA
HNB
Ameriprise's BPMC Position: Q3 2025 in Review
Ameriprise sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 18,199 shares — an estimated $2.33M sold.
Ameriprise first reported a position in BPMC in Q2 2015 and held it in 35 quarters. The position peaked at $32M in Q1 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Ameriprise reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Ameriprise sold 18,199 Blueprint Medicines shares in Q3 2025, an estimated $2.33M.
- Ameriprise first reported a position in Blueprint Medicines in Q2 2015 and held it in 35 quarters.
- Ameriprise's Blueprint Medicines position peaked at $32M in Q1 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Ameriprise's 13F filing for Q3 2025, filed 14 Nov 2025.